Uncategorized

Greffex, Inc., a company leading a paradigm shift in the design, development and production of vaccines, elected two new members to its board of directors on Monday. They are John D. White, founder and chairman of PSP Capital and former U.S. Ambassador to Qatar, Chase Untermeyer. Both are accomplished leaders and will bring significant global and national experience to Greffex, Inc.

“John and Chase are both strong leaders with impressive accomplishments and contributions that span across business and public service,” said John R. Price, Co-Chairman of the Board, President and Chief Executive of Greffex, Inc. “They will serve as valuable additions to the board.”

Read the full press release here

Greffex, Inc. and the Texas A&M University System (TAMUS) are excited to announce a collaboration on advanced process and manufacturing development. This agreement will advance the research and development of Greffex vaccines and assist the Health Science Center’s Center for Innovation in Advanced Development and Manufacturing (CIADM) at TAMUS to establish a robust, efficient pipeline of countermeasures to public health emergencies both in the US and worldwide.

From the press release:

“As we prepare for the next phase of research and development, we needed a creative, innovative “university-based” partner to assist us in our long-range development plans,” said John R. Price, President and CEO of Greffex, “and in Texas A&M Health Science Center’s Center for Innovation in Advanced Development and Manufacturing (CIADM), we found the creative, forward-thinking researchers who can leverage the resources of the entire university system.”

Read the full press release here